Blog
RSS FeedPosted by Michael Wonder on 02 Mar 2017
More government is not the remedy for high drug prices
2 March 2017 - The president has described drug prices as “astronomical” and vowed changes, including having the government negotiate ...
Posted by Michael Wonder on 02 Mar 2017
Republicans in Washington are in control, but not in agreement
2 March 2017 - Six weeks into unified government, Republican leaders are back to where they were in the Obama ...
Posted by Michael Wonder on 02 Mar 2017
Republican unity on health care is elusive, despite Trump’s support
2 March 2017 - President Trump’s address to Congress on Tuesday night buoyed House Republican leaders who were hopeful that ...
Posted by Michael Wonder on 02 Mar 2017
FDA accepts new drug application and grants priority review for enasidenib in relapsed or refractory AML with an IDH2 mutation
1 March 2017 - PDUFA date set for 30 August 2017. ...
Posted by Michael Wonder on 02 Mar 2017
Dynavax announces FDA acceptance for review of its complete response to November 2016 CRL and PDUFA action date for Heplisav-B
28 February 2017 - Dynavax Technologies announced today that the U.S. FDA has accepted for review Dynavax's responses to the complete ...
Posted by Michael Wonder on 01 Mar 2017
FDA approves Odactra for house dust mite allergies
1 March 2017 - The U.S. FDA today approved Odactra, the first allergen extract to be administered under the tongue (sublingually) ...
Posted by Michael Wonder on 01 Mar 2017
Drug benefit managers need more oversight, pharmacists say
28 February 2017 - Letter to HHS says pharmacy middlemen operate in ‘black box’. ...
Posted by Michael Wonder on 01 Mar 2017
Insurer windfalls aren't a solution to drug prices
1 March 2017 - As President Trump noted in his address to a joint session of Congress last night, health ...
Posted by Michael Wonder on 01 Mar 2017
Bernie Sanders takes another swing at big pharma with bill to allow drug imports
28 February 2017 - Opening a new front in the war against big pharma, Senator Bernie Sanders and a slew ...
Posted by Michael Wonder on 01 Mar 2017
Trump opposes required health benefits but reveals few details of his plan to end the ACA
28 February 2017 - In his first address to a joint session of Congress — a high-wattage moment to articulate ...
Posted by Michael Wonder on 01 Mar 2017
Orphan drug sales will outpace all other meds, thanks to high prices
28 February 2017 - As payers continue to foot the bill for orphan drugs, sales of these rare disease treatments ...
Posted by Michael Wonder on 01 Mar 2017
Trump derides ‘slow and burdensome’ approval process at FDA
28 February 2017 - President Trump on Tuesday called on the FDA to speed the approval of drugs to treat ...
Posted by Michael Wonder on 01 Mar 2017
Teva announces priority review granted by FDA for SD-809 for treatment of tardive dyskinesia
28 February 2017 - Teva Pharmaceutical Industries today announced the U.S. FDA has accepted the new drug application and granted ...
Posted by Michael Wonder on 01 Mar 2017
FDA accepts the biologics license application for avelumab for the treatment of metastatic urothelial carcinoma for priority review
28 February 2017 - Second biologics license application accepted by the FDA for avelumab. ...
Posted by Michael Wonder on 01 Mar 2017
Public-private partnership speeds investigator access to cancer drugs
28 February 2017 - A new collaboration between pharmaceutical and biotech companies and the National Cancer Institute at the National ...